Diversity of Natural Self-Derived Ligands Presented by Different HLA Class I Molecules in Transporter Antigen Processing-Deficient Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Lorente, Elena ^a   Infantes, Susana ^a   Barnea, Eilon ^b   Beer, Ilan ^b,d   Barriga, Alejandro ^a   García Medel, Noel ^c   Lasala, Fátima ^a   Jiménez, Mercedes ^a   Admon, Arie ^b   López, Daniel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d IBM HAIFA RESEARCH LAB   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; PEPTIDASE; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SECRETORY VESICLE; SIGNAL TRANSDUCTION;

ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CYTOSOL; ENDOPLASMIC RETICULUM; GENETIC VARIATION; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; HYBRIDOMAS; LIGANDS; MASS SPECTROMETRY; PEPTIDES; PROTEOLYSIS;

EID: 84875422824     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059118     Document Type: Article

References (60)

1. York IA, Goldberg AL, Mo XY, Rock KL, (1999) Proteolysis and class I major histocompatibility complex antigen presentation. Immunol Rev 172: 49-66.
2. Jensen PE, (2007) Recent advances in antigen processing and presentation. Nat Immunol 8: 1041-1048.
3. Cerundolo V, de la Salle H, (2006) Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense. Semin Immunol 18: 330-336.
4. van Kaer L, Ashton Rickardt PG, Ploegh HL, Tonegawa S, (1992) TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 71: 1205-1214.
5. Del Val M, López D, (2002) Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8+ T lymphocytes. Mol Immunol 39: 235-247.
6. Johnstone C, Del Val M, (2007) Traffic of proteins and peptides across membranes for immunosurveillance by CD8+ T Lymphocytes: A topological challenge. Traffic 8: 1486-1494.
7. Larsen MV, Nielsen M, Weinzierl A, Lund O, (2006) TAP-Independent MHC Class I Presentation. Current Immunology Reviews 2: 233-245.
8. Suri A, Walters JJ, Levisetti MG, Gross ML, Unanue ER, (2006) Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells. Eur J Immunol 36: 544-557.
9. Weinzierl AO, Rudolf D, Hillen N, Tenzer S, van Endert P, et al. (2008) Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry. Eur J Immunol 38: 1503-1510.
10. Salter RD, Howell DN, Cresswell P, (1985) Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235-246.
11. Erlich H, Lee JS, Petersen JW, Bugawan T, DeMars R, (1986) Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order. Hum Immunol 16: 205-219.
12. DeMars R, Chang CC, Shaw S, Reitnauer PJ, Sondel PM, (1984) Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum Immunol 11: 77-97.
13. Salter RD, Cresswell P, (1986) Impaired assembly and transport of HLA-A and-B antigens in a mutant TxB cell hybrid. EMBO J 5: 943-949.
14. Kuipers JG, Raybourne R, Williams KM, Zeidler H, Yu DT, (1996) Requirements for HLA-B*2705-binding peptides with special regard to the transporter associated with antigen processing (TAP). Clin Exp Rheumatol 14: 523-529.
15. Villadangos JA, Galocha B, Lopez de Castro JA, (1994) Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity. J Immunol 152: 2317-2323.
16. Infantes S, Lorente E, Barnea E, Beer I, Cragnolini JJ, et al. (2010) Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells. Mol Cell Proteomics 9: 1533-1539.
17. Lorente E, Infantes S, Barnea E, Beer I, Garcia R, et al. (2012) Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells. J Virol 86: 527-541.
18. Parham P, Bodmer WF, (1978) Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature 276: 397-399.
19. Ellis SA, Taylor C, McMichael A, (1982) Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol 5: 49-59.
20. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, et al. (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14: 9-20.
21. Ishihama Y, Rappsilber J, Andersen JS, Mann M, (2002) Microcolumns with self-assembled particle frits for proteomics. J Chromatogr A 979: 233-239.
22. Eng J, McCormack A, Yates J, (2009) An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Amer Soc Mass Spect 5: 976-989.
23. Wang M, Lamberth K, Harndahl M, Roder G, Stryhn A, et al. (2007) CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine 25: 2823-2831.
24. Fan QR, Garboczi DN, Winter CC, Wagtmann N, Long EO, et al. (1996) Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-CW4 class I Major Histocompatibility Complex molecule. Proc Natl Acad Sci U S A 93: 7178-7183.
25. López D, Samino Y, Koszinowski UH, Del Val M, (2001) HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope. J Immunol 167: 4238-4244.
26. Anderson KS, Alexander J, Wei M, Cresswell P, (1993) Intracellular transport of class I MHC molecules in antigen processing mutant cell lines. J Immunol 151: 3407-3419.
27. Rammensee HG, Bachmann J, Emmerich NPN, Bachor OA, Stevanovic S, (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
28. Ben Dror L, Barnea E, Beer I, Mann M, Admon A, (2010) The HLA-B*2705 peptidome. Arthritis Rheum 62: 420-429.
29. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
30. Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Lucius R, et al. (2011) Effector granules in human T lymphocytes: the luminal proteome of secretory lysosomes from human T cells. Cell Commun Signal 9: 4.
31. Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Lucius R, et al. (2011) Effector granules in human T lymphocytes: proteomic evidence for two distinct species of cytotoxic effector vesicles. J Proteome Res 10: 1603-1620.
32. Uriarte SM, Powell DW, Luerman GC, Merchant ML, Cummins TD, et al. (2008) Comparison of proteins expressed on secretory vesicle membranes and plasma membranes of human neutrophils. J Immunol 180: 5575-5581.
33. Mellman I, Fuchs R, Helenius A (1986) Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 55: 663-700. 10.1146/annurev.bi.55.070186.003311 [doi].
34. Brunner Y, Schvartz D, Coute Y, Sanchez JC (2009) Proteomics of regulated secretory organelles. Mass Spectrom Rev 28: 844-867. 10.1002/mas.20211 [doi].
35. Rawlings ND, Barrett AJ, Bateman A, (2010) MEROPS: the peptidase database. Nucleic Acids Res 38: D227-D233.
36. Lautscham G, Mayrhofer S, Taylor G, Haigh T, Leese A, et al. (2001) Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8+ T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway. J Exp Med 194: 1053-1068.
37. Lautscham G, Rickinson A, Blake N, (2003) TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus. Microbes Infect 5: 291-299.
38. Del Val M, Iborra S, Ramos M, Lázaro S, (2011) Generation of MHC class I ligands in the secretory and vesicular pathways. Cell Mol Life Sci 68: 1543-1552.
39. Lampen MH, Hassan C, Sluijter M, Geluk A, Dijkman K, et al. (2013) Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2. Mol Immunol 53: 126-131. S0161-5890(12)00356-2 [pii];10.1016/j.molimm.2012.07.009 [doi].
40. Apostolopoulos V, Karanikas V, Haurum JS, McKenzie IF, (1997) Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen. J Immunol 159: 5211-5218.
41. Fairchild PJ, Wraith DC, (1996) Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. Immunol Today 17: 80-85.
42. Oliveira CC, van Veelen PA, Querido B, de Ru A, Sluijter M, et al. (2009) The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. J Exp Med 207: 207-221.
43. Lorente E, Garcia R, López D, (2011) Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in TAP-deficient cells. J Biol Chem 286: 38054-38059.
44. Monastyrska I, Rieter E, Klionsky DJ, Reggiori F, (2009) Multiple roles of the cytoskeleton in autophagy. Biol Rev Camb Philos Soc 84: 431-448.
45. Suri A, Walters JJ, Kanagawa O, Gross ML, Unanue ER, (2003) Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition. Proc Natl Acad Sci U S A 100: 5330-5335.
46. Nelson CA, Roof RW, McCourt DW, Unanue ER, (1992) Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. Proc Natl Acad Sci U S A 89: 7380-7383.
47. Mukherjee P, Dani A, Bhatia S, Singh N, Rudensky AY, et al. (2001) Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis. J Immunol 167: 2632-2641.
48. Gromme M, UytdeHaag FG, Janssen H, Calafat J, van Binnendijk RS, et al. (1999) Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci U S A 96: 10326-10331.
49. Spies T, DeMars R, (1991) Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351: 323-324.
50. Suciu D, Chatterjee S, Inouye M, (1997) Catalytic efficiency of signal peptidase I of Escherichia coli is comparable to that of members of the serine protease family. Protein Eng 10: 1057-1060.
51. Wei ML, Cresswell P, (1992) HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356: 443-446.
52. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, et al. (1992) HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255: 1264-1266.
53. Samino Y, López D, Guil S, Saveanu L, van Endert PM, et al. (2006) A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein. J Biol Chem 281: 6358-6365.
54. Infantes S, Samino Y, Lorente E, Jiménez M, García R, et al. (2010) H-2Ld class I molecule protects an HIV N-extended epitope from in vitro trimming by endoplasmic reticulum aminopeptidase associated with antigen processing. J Immunol 184: 3351-3355.
55. Saric T, Chang SC, Hattori A, York IA, Markant S, et al. (2002) An IFN-g-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 3: 1169-1176.
56. Serwold T, González F, Kim J, Jacob R, Shastri N, (2002) ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419: 480-483.
57. Saveanu L, Carroll O, Lindo V, Del Val M, López D, et al. (2005) Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 6: 689-697.
58. Gil-Torregrosa BC, Castaño AR, López D, Del Val M, (2000) Generation of MHC class I peptide antigens by protein processing in the secretory route by furin. Traffic 1: 641-651.
59. Shen XZ, Billet S, Lin C, Okwan-Duodu D, Chen X, et al. (2011) The carboxypeptidase ACE shapes the MHC class I peptide repertoire. Nat Immunol 12: 1078-1085.
60. Lorente E, Garcia R, Mir C, Barriga A, Lemonnier FA, et al. (2012) Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation. J Biol Chem 287: 9990-10000.